PGNY.NASDAQProgyny, INC

Form 4: Progyny Executive Allison Swartz Reports Stock Transactions

Sentiment:

SEC Form 4


EVP, GC of Progyny, Allison Swartz, reports acquisition of stock options and restricted stock units, as well as disposal of shares for tax obligations.

Summary

  • On March 3, 2025, Allison Swartz, EVP, GC of Progyny, Inc., acquired 22,727 shares of common stock representing restricted stock units (RSUs) at $0, and 31,115 stock options at $0.
  • These grants were made under the company's 2019 Equity Incentive Plan.
  • 33% of the RSUs and stock options will vest on the first anniversary of the grant date, with the remainder vesting quarterly over the following two years, contingent upon continued service.
  • On March 4, 2025, 1,417 shares of common stock were disposed of at $22 to cover withholding taxes related to the vesting of RSUs.
  • Following these transactions, Swartz directly owns 83,786 shares of Progyny common stock and 31,115 stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Positives

  • The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
  • The vesting schedule encourages continued service with the company.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is typical for publicly traded companies.

Comparison to Industry Standards

  • Equity grants are a common component of executive compensation packages in publicly traded companies, particularly in the tech and healthcare sectors.
  • Vesting schedules, such as the one described (33% on the first anniversary, then quarterly), are standard practice to incentivize long-term commitment.
  • Companies like Teladoc Health, Accolade, and Livongo (now part of Teladoc) also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
  • Employees may be indirectly affected by the incentive structure for executives.

Key Dates

DateDescription
03/03/2025Date of RSU and stock option grant
03/03/2025Date stock options become exercisable
03/04/2025Date of share disposal for tax obligations
03/02/2035Expiration date of stock options
03/05/2025Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.